Online Program

Return to main conference page
Tuesday, September 24
Tue, Sep 24, 10:15 AM - 11:30 AM
Thurgood Marshall Ballroom
Plenary Session 2

Panel Discussion (301054)

*Aloka Chakravarty, FDA/CDER 
*Ram Tiwari, FDA/CDRH 
*John Scott, FDA/CBER 
*Mike Branson, Celgene 
*William Wang, Merck & Co., Inc. 
*Mark van der Laan, UC Berkeley 

The panel will feature six experts from industry, regulatory and academia. We expect a lively dialogue answering questions in their respective area of expertise pertaining to the workshop theme of From Small Data to Big Data, from RCT to RWE, the Impact of Statistics. Below is brief information on the panel members.

Aloka Chakravarty, PhD, is the Deputy Director of the Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA).

Ram Tiwari, PhD, is the Director of the Division of Biostatistics, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, FDA

John Scott, PhD, is the Director of Biostatistics, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, FDA.

Mike Branson, PhD, is VP Global Head Biometrics, Celgene Corporations.

William Wang, PhD, is Executive Director, Clinical Safety Statistics, Merck Research Laboratories.

Mark van der Laan, PhD, is the Jiann-Ping Hsu/Karl E. Peace Professor of Biostatistics and Statistics at the University of California, Berkeley.